Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1073
mi
from
Wilmington, NC
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1073
mi
from
Wilmington, NC
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1080
mi
from
Cincinati, OH
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1080
mi
from
Cincinati, OH
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1078
mi
from
Cleveland, OH
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1078
mi
from
Cleveland, OH
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1082
mi
from
Dayton, OH
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1082
mi
from
Dayton, OH
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1017
mi
from
Mentor, OH
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1017
mi
from
Mentor, OH
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1064
mi
from
Lancaster, PA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1064
mi
from
Lancaster, PA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1066
mi
from
Sayre, PA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1066
mi
from
Sayre, PA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1059
mi
from
Austin, TX
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1059
mi
from
Austin, TX
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1019
mi
from
Houston, TX
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1019
mi
from
Houston, TX
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1004
mi
from
Houston, TX
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1004
mi
from
Houston, TX
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1005
mi
from
Pasadena, TX
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1005
mi
from
Pasadena, TX
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1048
mi
from
The Woodlands, TX
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1048
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1014
mi
from
Lancaster, UT
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1014
mi
from
Lancaster, UT
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1020
mi
from
Ogden, UT
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1020
mi
from
Ogden, UT
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1038
mi
from
Chesapeake, VA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1038
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1025
mi
from
Christianburg, VA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1025
mi
from
Christianburg, VA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1007
mi
from
Richmond, VA
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1007
mi
from
Richmond, VA
Click here to add this to my saved trials
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated:  6/19/2013
Santarus Clinical Investigational Site 1036
mi
from
Madison, WI
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Status: Enrolling
Updated: 6/19/2013
Santarus Clinical Investigational Site 1036
mi
from
Madison, WI
Click here to add this to my saved trials
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
Status: Enrolling
Updated:  6/20/2013
Woodrow Wilson Rehabilitation Center
mi
from
Fishersville, VA
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
Status: Enrolling
Updated: 6/20/2013
Woodrow Wilson Rehabilitation Center
mi
from
Fishersville, VA
Click here to add this to my saved trials
Uncertainty Management Intervention
Uncertainty Management Intervention for Patients Awaiting Liver Transplant
Status: Enrolling
Updated:  6/26/2013
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Uncertainty Management Intervention
Uncertainty Management Intervention for Patients Awaiting Liver Transplant
Status: Enrolling
Updated: 6/26/2013
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Uncertainty Management Intervention
Uncertainty Management Intervention for Patients Awaiting Liver Transplant
Status: Enrolling
Updated:  6/26/2013
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Uncertainty Management Intervention
Uncertainty Management Intervention for Patients Awaiting Liver Transplant
Status: Enrolling
Updated: 6/26/2013
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Uncertainty Management Intervention
Uncertainty Management Intervention for Patients Awaiting Liver Transplant
Status: Enrolling
Updated:  6/26/2013
Duke University
mi
from
Durham, NC
Uncertainty Management Intervention
Uncertainty Management Intervention for Patients Awaiting Liver Transplant
Status: Enrolling
Updated: 6/26/2013
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Uncertainty Management Intervention
Uncertainty Management Intervention for Patients Awaiting Liver Transplant
Status: Enrolling
Updated:  6/26/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Uncertainty Management Intervention
Uncertainty Management Intervention for Patients Awaiting Liver Transplant
Status: Enrolling
Updated: 6/26/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Watchful Waiting Versus Open Tension-free Repair of Inguinal Hernia in Asymptomatic or Minimally Symptomatic Men
Watchful Waiting Versus Open Tension-free Repair of Inguinal Hernia in Asymptomatic or Minimally Symptomatic Men
Status: Enrolling
Updated:  6/28/2013
American College of Surgeons
mi
from
Chicago, IL
Watchful Waiting Versus Open Tension-free Repair of Inguinal Hernia in Asymptomatic or Minimally Symptomatic Men
Watchful Waiting Versus Open Tension-free Repair of Inguinal Hernia in Asymptomatic or Minimally Symptomatic Men
Status: Enrolling
Updated: 6/28/2013
American College of Surgeons
mi
from
Chicago, IL
Click here to add this to my saved trials
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Venous Leg Ulcers
Status: Enrolling
Updated:  7/4/2013
Penn North Centers for Advance Wound Care
mi
from
Eire, PA
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Venous Leg Ulcers
Status: Enrolling
Updated: 7/4/2013
Penn North Centers for Advance Wound Care
mi
from
Eire, PA
Click here to add this to my saved trials
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test on DFU
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Diabetic Foot Ulcers
Status: Enrolling
Updated:  7/4/2013
Penn North Centers for Advance Wound Care
mi
from
Eire, PA
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test on DFU
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Diabetic Foot Ulcers
Status: Enrolling
Updated: 7/4/2013
Penn North Centers for Advance Wound Care
mi
from
Eire, PA
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Birmingham, AL
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Baltimore, MD
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Boston, MA
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Jackson, MS
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Charleston, SC
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Dallas, TX
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Insulin Resistance in Non-alcoholic Fatty Liver Disease
Insulin Resistance in Non-alcoholic Fatty Liver Disease (Protocol Drug Change From Project CDA-2-044-08S)
Status: Enrolling
Updated:  7/8/2013
VA Puget Sound Health Care System, Seattle
mi
from
Seattle, WA
Insulin Resistance in Non-alcoholic Fatty Liver Disease
Insulin Resistance in Non-alcoholic Fatty Liver Disease (Protocol Drug Change From Project CDA-2-044-08S)
Status: Enrolling
Updated: 7/8/2013
VA Puget Sound Health Care System, Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases
Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases
Status: Enrolling
Updated:  7/10/2013
University of Kentucky Medical Center
mi
from
Lexington, KY
Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases
Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases
Status: Enrolling
Updated: 7/10/2013
University of Kentucky Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
Stanford Univ. School of Medicine - Palo Alto VA Health Care System
mi
from
Palo Alto, CA
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
Stanford Univ. School of Medicine - Palo Alto VA Health Care System
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
University of Connecticut Health Center - Division of Rheumatic Diseases
mi
from
Farmington, CT
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
University of Connecticut Health Center - Division of Rheumatic Diseases
mi
from
Farmington, CT
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
Georgetown University
mi
from
Washington,
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
Millennium Research
mi
from
Ormond Beach, FL
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
Millennium Research
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
Cleveland Clinic Florida
mi
from
Weston, FL
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
Cleveland Clinic Florida
mi
from
Weston, FL
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
Florida Medical Clinic, PA
mi
from
Zephyrhills, FL
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
Florida Medical Clinic, PA
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
Northwestern University - Feinberg School of Medicine Department of Rheumatology
mi
from
Chicago, IL
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
Northwestern University - Feinberg School of Medicine Department of Rheumatology
mi
from
Chicago, IL
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
Boston University School of Medicine
mi
from
Boston, MA
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
Washington University School of Medicine
mi
from
St Louis, MO
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
Washington University School of Medicine
mi
from
St Louis, MO
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
North Shore Long Island Jewish Health System - Div. of Rheumatology & Allergy-Clinical Immunology
mi
from
Lake Success, NY
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
North Shore Long Island Jewish Health System - Div. of Rheumatology & Allergy-Clinical Immunology
mi
from
Lake Success, NY
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
Hospital for Special Surgery
mi
from
New York, NY
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated:  7/11/2013
Ruppert Health Center
mi
from
Toledo, OH
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis
Status: Enrolling
Updated: 7/11/2013
Ruppert Health Center
mi
from
Toledo, OH
Click here to add this to my saved trials